FOXD2 and central nervous system cancer: Furthermore, compared with those in the control and empty vector cells, FOXD2-As1 overexpression significantly reduced the ratio of methylated MGMT promoter DNA and promoted MGMT protein expression in TMZ-resistant glioma cells (Figure 7C).